Franklin Biotechnology Disc A Acc $

Performance History31/07/2015
Growth of 1,000 (EUR)
Franklin Biotechnology Disc A Acc $
Fund13.324.957.253.432.8
+/-Cat11.40.26.04.9-0.1
+/-Idx-5.6-16.9-3.34.55.7
 
Key Stats
NAV
26/08/2015
 USD 33.80
Day Change 6.21%
Morningstar Category™ Sector Equity Biotechnology
ISIN LU0109394709
Fund Size (Mil)
31/07/2015
 USD 3203.94
Share Class Size (Mil)
31/07/2015
 USD 2597.78
Max Initial Charge 5.75%
Ongoing Charge
30/06/2015
  1.81%
Investment Objective: Franklin Biotechnology Disc A Acc $
The Fund’s investment objective is capital appreciation. The Fund invests principally in equity securities of biotechnology companies and discovery research firms (including small to mid-sized companies) located in the US and other countries, and to a lesser extent in debt securities of any type of issuers worldwide.
Returns
Trailing Returns26/08/2015
YTD16.14
3 Years Annualised38.23
5 Years Annualised34.96
10 Years Annualised16.31
12 Month Yield 0.00
Management
Manager Name
Start Date
Evan McCulloch
01/11/2000
Jerel Banks
01/09/2012
Inception Date
03/04/2000
Advertisement
Benchmarks
Fund BenchmarkMorningstar Benchmark
NASDAQ Biotechnology TR USDMSCI World/Biotechnology NR USD
Portfolio Profile for  Franklin Biotechnology Disc A Acc $30/04/2015
Morningstar Style Box®
Equity Style
Asset Allocation
  % Long% Short% Net Assets
Stocks91.400.0091.40
Bonds0.000.000.00
Cash8.430.008.43
Other0.170.000.17
Top 5 Regions%
United States95.19
United Kingdom2.90
Canada1.07
Middle East0.31
Eurozone0.31
Top 5 Sectors%
Healthcare100.00
Top 5 HoldingsSector%
Gilead Sciences IncHealthcareHealthcare8.43
Celgene CorpHealthcareHealthcare8.19
Biogen IncHealthcareHealthcare6.82
Amgen IncHealthcareHealthcare4.69
Incyte CorpHealthcareHealthcare3.59
Franklin Biotechnology Disc A Acc $